The neurobiology of suicide

Nature Medicine

Volumn 4, Issue 1, 1998, Pages 25-30

  John Mann, J ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLISM; COMORBIDITY; DEPRESSION; EPILEPSY; HUMAN; HUNTINGTON CHOREA; PATHOPHYSIOLOGY; PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCHOANALYSIS; REVIEW; SCHIZOPHRENIA; STRESS; SUBSTANCE ABUSE; SUICIDE;

AGGRESSION; BRAIN; HUMANS; MODELS, NEUROLOGICAL; MODELS, PSYCHOLOGICAL; PSYCHOTROPIC DRUGS; STRESS, PSYCHOLOGICAL; SUICIDE; SUICIDE, ATTEMPTED; TREATMENT FAILURE;

EID: 2642619386     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0198-025     Document Type: Review

References (76)

1. Center for Disease Control and Prevention, Advance report of final mortality statistics, 1990. Monthly Vital Statistics Report 41, 1-52 (1993).
2. Jamison, K.R. Suicide and bipolar disorders. Ann. N. Y. Acad. Sci. 487, 301-315 (1986).
3. Johns, C.A., Stanley, M. & Stanley, B. Suicide in schizophrenia. Ann. N. Y. Acad. Sci. 487, 294-300 (1986).
4. Roy, A. & Linnoila, M. Alcoholism and suicide. Suicide Life Threat. Behav. 16, 244-273 (1986).
5. Frances, A., Fyer, M. & Clarkin, J. Personality and Suicide. Ann. N. Y. Acad. Sci. 487, 281-293 (1986).
6. Beck, A.T., Weissman, A., Lester, D. & Trexler, L. Classification of suicidal behaviors. II. Dimensions of suicidal intent. Arch. Gen. Psychiatry 33, 835-837 (1976).
7. Stengel, E. Suicide and Attempted Suicide (C. Nicholls & Company Ltd. Harmondsworth, Middlesex, 1973).
8. Barraclough, B., Bunch, J., Nelson, B. & Sainsbury, P. One hundred cases of suicide. Clinical aspects, Br. J. Psychiatry 125, 355-373 (1974).
9. Robins, E., Murphy, G.E., Wilkinso, R.H., Gessner, F. & Kayes, J. Some clinical considerations in the prevention of suicide based on a study of 134 successful suicides. Am. J. Public Health 49, 888-899 (1979).
10. Rich, C.L., Fowler, R.C., Fogarty, L.A. & Young, D. San Diego suicide study. III. Relationships between diagnoses and Stressors. Arch. Gen. Psychiatry 45, 589-592 (1988).
11. Dorpat, T.L. & Ripley, H.S. A study of suicide in the Seattle area. Compr. Psychiatry 1, 349-359 (1960).
12. Isometsä, E., et al. Mental disorders in young and middle aged men who commit suicide. BMJ 310, 1366-1367 (1995).
13. Malone, K.M., Haas, G.L., Sweeney, J.A. & Mann, J.J. Major depression and the risk of attempted suicide. J. Affect. Disord. 34, 173-185 (1995).
14. Roy, A., Segal, N.L., Centerwall, B.S. & Robinette, C.D. Suicide in twins. Arch. Gen. Psychiatry 48, 29-32 (1991).
15. Roy, A., Segal, N.L. & Sarchiapone, M. Attempted suicide among living co-twins of twin suicide victims. Am. J. Psychatry 152, 1075-1076 (1995).
16. Schulsinger, F., Kety, S.S., Rosenthal, D. & Wender, P.H. A family study of suicide. In Origin, Prevention And Treatment Of Affective Disorders (ed. Schou, M. & Stromgren, E.) 277-287 (Academic Press, New York, 1979).
17. Brodsky, B.S., Malone, K.M., Ellis, S.P., Dulit, R.A. & Mann, J.J. Borderline personality disorder characteristics associated with suicidal behavior, Am. J. Psychiatry (1997) (In Press)
18. Brent, D.A. Overrepresentation of epileptics in a consecutive series of suicide attempters seen at a Children's Hospital, 1978-1983. J. Am. Acad. Child Psychiatry 25, 242-246 (1986).
19. Breslau, N., Davis, G.C. & Andreski, P. Migraine, psychiatric disorders, and suicide attempts: An epidemiologic study of young adults. Psychiatry Res. 37, 11-23 (1991).
20. Schoenfeld, M. et al. increased rate of suicide among patients with Huntington's disease. J. Neurol. Neurosurg. Psychiatry 47, 1283-1287 (1984).
21. Farrer, L.A. Suicide and attempted suicide in Huntington disease: Implications for preclinical testing of persons at risk. Am. J. Med. Genet. 24, 305-311 (1986).
22. Roy, A., Lamparski, D., Dejong, J., Moore, V. & Linnoila, M. Characteristics of alcoholics who attempt suicide. Am. J. Psychiatry 147, 761-765 (1990).
23. Roy, A. et al. Cerebrospinal fluid monoamine metabolites in alcoholic patients who attempt suicide. Acta Psychiatr. Scand. 81, 58-61 (1990).
24. Murphy, G.E. & Wetzel, R.D. The lifetime risk of suicide in alcoholism. Arch. Gen. Psychiatry 47, 383-392 (1990).
25. Murphy, G.E., Wetzel, R.D., Robins, E. & McEvoy, L. Multiple risk factors predict suicide in alcoholism. Arch. Gen. Psychiatry 49, 459-463 (1992).
26. Murphy, G.E. Suicide and substance abuse. Arch. Gen. Psychiatry 45, 593-594 (1988).
27. Dulit, R.A., Fyer, M.R., Haas, G.L., Sullivan, T. & Frances, A.J. Substance use in borderline personality disorder. Am. J. Psychiatry 147, 1002-1007 (1990).
28. Marzuk, P.M. & Mann, J.J. Suicide and substance abuse. Psychiatric Annals 18, 639-645 (1988).
29. Muldoon, M.F., Manuck, S.B. & Matthews, K.A. Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials. Br. Med. J. 301, 309-314 (1990).
30. Muldoon, M.F. et al. Low or lowered cholesterol and risk of death from suicide and trauma. Metabolism 42 Suppl. 1, 45-56 (1993).
31. Bulik, C.M., Carpenter, L.L., Kupfer, D.J. & Frank, E. Features associated with suicide attempts in recurrent major depression. J. Affect. Disord. 18, 29-37 (1990).
32. Roose, S.P., Classman, A.H., Walsh, B.T., Woodring, S. & Vital-Herne, J. Depression, delusions, and suicide. Am. J. Psychiatry 140, 1159-1162 (1983).
33. Weissman, M.M., Klerman, G.L., Markowitz, J.S. & Ouellette, R. Suicidal ideation and suicide attempts in panic disorder and attacks. N. Engl. J. Med. 321, 1209-1214 (1989).
34. Weiden, P.J., Sweeney, J.A., Haas, G.L. & Goldman, D. Phase of illness and suicide in schizophrenia, Schizophr. Res. 4, 379(Abstract) (1991).
35. Mann, J.J., Underwood, M.D. & Arango, V. Postmortem studies of suicide victims. In Biology of Schizophrenia and Affective Disease (ed. Watson, S.J.) 197-220 (American Psychiatric Press, Inc. Washington, DC, 1996).
36. 3H-Paroxetine binding in cerebral cortex of suicide victims is partly due to fewer high-affinity, non-transporter sites. J. Neural fromm. 103, 1337-1350 (1996).
37. Arango, V., Underwood, M.D., Gubbi, A.V. & Mann, J.J. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 688, 121-133 (1995).
38. Shallice, T. & Burgess, P. The domain of supervisory processes and temporal organization of behaviour. Phil. Trans. R. Soc. Lond. 351, 1405-1412 (1996).
39. Damasio, H., Grabowski, T., Frank, R., Galaburda, A.M. & Damasio, A.R. The return of Phineas Gage: Clues about the brain from the skull of a famous patient. Science 264, 1102-1105 (1994).
40. Mann, J.J. Violence and aggression. In Psychopharmacology: The Fourth Generation of Progressed. Bloom, F.E. & Kupfer, D.J.) (Raven Press, New York, 1994).
41. Mann, J.J., Arango, V., Marzuk, P.M., Theccanat, S. & Reis, D.J. Evidence for the 5-HT hypothesis of suicide: A review of post-mortem studies. Br. J. Psychiatry 155 (Suppl. 8), 7-14 (1989).
42. Åsberg, M., Nordström, P. & Tråskman-Bendz, L. Cerebrospinal fluid studies in suicide. An overview. Ann. N. Y. Acad. Sci. 487, 243-255 (1986).
43. Arango, V., Underwood, M.D. & Mann, J.J. Fewer pigmented locus coeruleus neurons in suicide victims: Preliminary results. Biol. Psychiatry 39, 112-120 (1996).
44. Ordway, C.A., Widdowson, P.S., Smith, K.S. & Halaris, A. Agonist binding to αadrenoceptors is elevated in the locus coeruleus from victims of suicide. J. Neurochem. 63, 617-624 (1994).
45. Ordway, G.A., Smith, K.S. & Haycock, J.W. Elevated tyrosine hydroxylase in the locus coeruleus of suicide victims. J. Neurochem. 62, 680-685 (1994).
46. 2 adrenergic receptors in the cerebral cortex of controls and suicide victims. Brain Res. 630, 271-282 (1993).
47. Weiss, G.K. et al. The effect of two different types of stress on locus coeruleus alpha-2 receptor binding. Brain Res. Bull. 33, 219-221 (1994).
48. Weiss, J.M. et al. Depression and anxiety: Role of the locus coeruleus and corticotropin-releasing factor. Brain Res. Bull. 35, 561-572 (1994).
49. Traskman, L., Åsberg, M., Bertilsson, L. & Sjöstrand, L. Monoamine metabolites in CSF and suicidal behavior. Arch. Gen. Psychiatry 38, 631-636 (1981).
50. Kapur, S. & Mann, J.J. Role of the dopaminergic system in depression. Biol. Psychiatry 32, 1-17(1992).
51. Higley, J.D. et al. Paternal and maternal genetic and environmental contributions to cerebrospinal fluid monoamine metabolites in Rhesus monkeys (Macaca mulatta). Arch. Gen. Psychiatry 50, 615-623 (1993).
52. Carroll, B.J. et al. A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Arch. Gen. Psychiatry 38, 15-22 (1981).
53. Bunney, W.E., Jr., Fawcett, J.A., Davis, J.M. & Gifford, S. Further evaluation of urinary 17-Hydrocorticosteroids in suicidal patients. Arch. Gen. Psychiatry 21, 138-150 (1969).
54. Nemeroff, C.B., Owens, M.J., Bissette, G., Andorn, A.C. Se Stanley, M. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch. Gen. Psychiatry 45, 577-579 (1988).
55. Mann, J.J. et al. Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed inpatients. Neuropsychopharmacology 15, 576-586 (1996).
56. Nordstrom, P. et al. CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat. Behav. 24, 1-9 (1994).
57. Roy, A. et al. Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-Hydroxyindoleacetic acid ratios in depressed patients: Relationship to suicidal behavior and dexamethasone nonsuppression. Am. J. Psychiatry 143, 1539-1545 (1986).
58. Cooper, S.J., Kelly, C.B. & King, D.J. 5-Hydroxyindoleacetic acid in cerebrospinal fluid and prediction of suicidal behaviour in schizophrenia. Lancet 340, 940-941 (1992).
59. Mann, J.J., McBride, P.A., Malone, K.M., DeMeo, M.D. & Keilp, J. Blunted serotonergic responsivity in depressed patients. Neuropsychopharmacology 13, 53-64 (1995).
60. Coccaro, E.F. et al. Serotonergic studies in patients with affective and personality disorders. Arch. Gen. Psychiatry 46, 587-599 (1989).
61. Mann, J.J. & Malone, K.M. Cerebrospinal fluid amines and higher lethality suicide attempts in depressed inpatients. Biol Psychiatry 41, 162-171 (1997).
62. Pandey, C.N., Pandey, S.C., janicak, P.C., Marks, R.C. & Davis, J.M. Platelet serotonin-2 receptor binding sites in depression and suicide. Biol. Psychiatry 28, 215-222 (1990).
63. Nielsen, D.A. et al. Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Arch. Gen. Psychiatry 51, 34-38 (1994).
64. Mann, J.J. et al. A polymorphism of the tryptophan hydroxylase gene appears associated with suicidal behavior in depressed patients. Am. J. Psychiatry 154, 1451-1453 (1997).
65. Brown, G.L. & Coodwin, F.K. Cerebrospinal fluid correlates of suicide attempts and aggression. Ann. N. Y. Acad. Sci. 487, 175-188 (1986).
66. Virkkunen, M., De Jong, J., Bartko, J. & Linnoila, M. Psychobiological concomitants of history of suicide attempts among violent offenders and impulsive fire setters. Arch. Gen. Psychiatry 46, 604-606 (1989).
67. Brown, C.L., Goodwin, F.K. & Bunney, W.E., Jr. Human aggression and suicide Their relationship to neuropsychiatric diagnoses and serotonin metabolism. Adv. Biochem. Psychopharmaml. 34, 287-307 (1982).
68. Brown, G.L., Goodwin, F.K., Ballenger, J.C., Goyer, P.F. & Major, L.F. Aggression in human correlates with cerebrospinal fluid amine metabolites. Psychiatry Res. 1, 131-139 (1979).
69. Linnoila, M et al. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from non-impulsive violent behavior. Life Sci. 33, 2609-2614 (1983).
70. Virkkunen, M., De long, J., Bartko, J., Goodwin, F.K. & Linnoila, M. Relationship of psychobiological variables to recidivism in violent offenders and impulsive fire setters. A follow-up study. Arch. Gen. Psychiatry 46, 600-603 (1989).
71. Higley, J.D. et al. Cerebrospinal fluid monoamine and adrenal correlates of aggression in free-ranging Rhesus monkeys. Arch. Cen. Psychiotry 49, 436-441 (1992).
72. Kaplan, J.R. et al. Demonstration of an association among dietary cholesterol, central serotonergic activity, and social behavior in monkeys. Psychosom. Med. 56, 479-484 (1994).
73. Isometsa, E., Henriksson, M., Heikkinen, M., Aro, H, & Lonnqvist, J. Suicide and the use of antidepressants. Drug treatment of depression is inadequate. BMJ 308, 915 (1994).
74. Rutz, W., Von Knorring, L. & W-linder, J. Frequency of suicide on Gotland after systematic postgraduate education of general practitioners. Acta Psychiatr. Scand. 80, 151-154 (1989).
75. Kapur, S., Mieczkowski, T. & Mann, J.J. Antidepressant medications and the relative risk of suicide attempt and suicide. J. Am. Med. Assoc. 268, 3441-3445 (1992).
76. Boyd, J.H. The increasing rate of suicide by firearms. N. Engi J. Med. 308(15), 872-874 (1983).